11
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Oral platinum analogue JM216, a radiosensitizer in oxic murine cells

Pages 675-683 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Junko Takahashi, Masaki Misawa & Hitoshi Iwahashi. (2016) Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone. International Journal of Radiation Biology 92:12, pages 774-789.
Read now

Articles from other publishers (9)

Helena C. Besse, Clemens Bos, Maurice M. J. M. Zandvliet, Kim van der Wurff-Jacobs, Chrit T. W. Moonen & Roel Deckers. (2018) Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study. PLOS ONE 13:9, pages e0204063.
Crossref
Lea Baer, Franco M. Muggia & Silvia C. Formenti. 2009. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy 211 223 .
M. A. Jakupec, M. S. Galanski & B. K. Keppler. 2003. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology 1 53 .
Christopher M. George, Dan J. Haraf, Ann M. Mauer, Stuart A. Krauss, Philip C. Hoffman, Charles M. Rudin, Livia Szeto & Everett E. Vokes. (2001) A Phase I Trial of the Oral Platinum Analogue JM216 with Concomitant Radiotherapy in Advanced Malignancies of the Chest. Investigational New Drugs 19:4, pages 303-310.
Crossref
Paul J. M. van de Vaart, Jose Belderbos, Daphne de Jong, Kommer C.A. Sneeuw, Donne Majoor, Harry Bartelink & Adrian C. Begg. (2000) DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy. International Journal of Cancer 89:2, pages 160-166.
Crossref
George P Amorino, Michael L Freeman, David P Carbone, David E Lebwohl & Hak Choy. (1999) Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition. International Journal of Radiation Oncology*Biology*Physics 44:2, pages 399-405.
Crossref
Lois B. Travis, Eric J. Holowaty, Kjell Bergfeldt, Charles F. Lynch, Betsy A. Kohler, Tom Wiklund, Rochelle E. Curtis, Per Hall, Michael Andersson, Eero Pukkala, Jeremy Sturgeon, Hans Storm, E. Aileen Clarke, John D. BoiceJr.Jr., Mary Gospodarowicz & Marilyn Stovall. (1999) Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer. New England Journal of Medicine 340:5, pages 351-357.
Crossref
Zijian Guo & Peter J. Sadler. 1999. 183 306 .
C. F. J. Barnard, F. I. Raynaud & L. R. Kelland. 1999. Metallopharmaceuticals I. Metallopharmaceuticals I 45 71 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.